OR WAIT null SECS
April 08, 2022
FDA has granted Priority Review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalized adults.
NIH has announced four new grant awards to fund new tuberculosis research advancement centers.
April 02, 2022
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
March 10, 2022
Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.
February 23, 2022
Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.
February 10, 2022
PharmTech interviewed Sartorius about SUS innovations and trends.
February 07, 2022
The acquisition will include Rewrite’s DNA writing platform, expanding Intellia’s genome editing tools.
February 03, 2022
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.
January 11, 2022
The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.